ArticlePharmaceuticals (Basel, Switzerland)2012

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's Disease.

Marcus J Calkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.